Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation

KL-6 is an antigen produced mainly by damaged type II pneumocytes that is involved in interstitial lung disease. Chronic lung allograft dysfunction (CLAD) after lung transplantation (LT) is a major concern for LT clinicians, especially in patients with restrictive allograft syndrome (RAS). We invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Berastegui, Cristina, Gómez-Ollés, Susana, Mendoza-Valderrey, Alberto, Pereira-Veiga, Thais, Culebras, Mario, Monforte, Victor, Saez, Berta, López-Meseguer, Manuel, Sintes-Permanyer, Helena, Ruiz de Miguel, Victoria, Bravo, Carlos, Sacanell, Judit, Ramon, María-Antonia, Romero, Laura, Deu, María, Román, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957146/
https://www.ncbi.nlm.nih.gov/pubmed/31929536
http://dx.doi.org/10.1371/journal.pone.0226488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957146/
https://www.ncbi.nlm.nih.gov/pubmed/31929536
http://dx.doi.org/10.1371/journal.pone.0226488

Ejemplares similares